Published in Vaccine Weekly, September 13th, 2006
"The development of a vaccine to prevent infection with group A streptococcus (GAS) is hampered by the widespread diversity of circulating GAS strains and M protein types, and it is widely believed that a multivalent vaccine would provide better protective immunity," according to investigators in Australia.
"We investigated the efficacy of incorporating 3 M protein serotypic amino-terminal...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly